Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Multiple Myeloma 5Lymphoma 3Plasmacytoma 2Paraproteinemias 2Leukemia, Plasma Cell 2Hemangioma 2Breast Neoplasms 2Recurrence 1Prostatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Lymphocytic, Chronic, B-Cell 1Head and Neck Neoplasms 1Glioma 1Gallstones 1Disease Progression 1Common Bile Duct Neoplasms 1Common Bile Duct Diseases 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1Brain Neoplasms 1

Interventions

Cyclophosphamide 85Rituximab 80Peripheral Blood Stem Cell Transplantation 60fludarabine phosphate 58Filgrastim 40Mycophenolic Acid 37Whole-Body Irradiation 35Cyclosporine 35Radiotherapy 33Etoposide 33Busulfan 33Tacrolimus 31Antilymphocyte Serum 28Melphalan 26Methotrexate 22Prednisone 19Bortezomib 19Methylprednisolone 16Cytarabine 16Vincristine 15Lenalidomide 15Flow Cytometry 14Cord Blood Stem Cell Transplantation 13sargramostim 12Doxorubicin 12Bendamustine Hydrochloride 12fludarabine 11Dexamethasone 11Carmustine 11Carboplatin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Lymphoma, B-Cell, Marginal Zone × Steroids × Clear all
NCT00004112 2024-09-23

Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma

University of Nebraska

Phase 3 Completed
LymphoidOther hematologic neoplasm

Lymphoma, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡